Experienced in Hypercalcemia

Yong M. He

#37 Guo Xue Lane, 
Chengdu, CN 
Experienced in Hypercalcemia
#37 Guo Xue Lane, 
Chengdu, CN 
OverviewLocationsClinical Research

Overview

Yong He practices in Chengdu, China. He is rated as an Experienced expert by MediFind in the treatment of Hypercalcemia. Their top areas of expertise are Coronary Heart Disease, Heart Attack, Hypertrophic Cardiomyopathy (HCM), Percutaneous Coronary Intervention (PCI), and Lithotripsy.

Their clinical research consists of co-authoring 213 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Hypercalcemia.

Locations

#37 Guo Xue Lane, Chengdu, 610041, China
Other Locations
State Key Laboratory Of Drug Research, Shanghai, China
20# South Renmin Road, Chengdu, 610041, China
218 Jixi Street, Hefei, 230022, China
Meishan Road, Hefei, 230032, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Heart Failure With Preserved Ejection Fraction and Obesity (SUMMIT)
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Heart Failure With Preserved Ejection Fraction and Obesity (SUMMIT)
Enrollment Status: Completed
Publish Date: August 20, 2025
Intervention Type: Other, Drug
Study Drug: Tirzepatide
Study Phase: Phase 3

213 Total Publications

Alcohol consumption potentiates second-hit events in HBV-induced hepatocellular carcinoma.
Alcohol consumption potentiates second-hit events in HBV-induced hepatocellular carcinoma.
Journal: Journal of hepatology
Published: September 18, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find He's expertise for a condition
ConditionClose
      View All 58 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile